Cardiac Resynchronization Therapy Based Heart Failure Monitoring Study

Phase 2

Completed

• Conditions: Heart Failure; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12608000267358
• Lead Sponsor: St Jude Medical

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-05-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 12

Inclusion Criteria

Age>18 and <=85;an approved indication for cardiac resynchronization therapy via pacemaker(CRT-P) or cardiac resynchronization therapy via defibrillator(CRT-D);may be a Homeostasis 1 trial participant;able and willing to participate as per the trial protocol.

Exclusion Criteria

Intractable Heart Failure or listed for cardiac transplantation; Acute Myocardial Infarction or Acute Coronary Syndrome; Recent surgery or (Percutaneous Coronary Intervention(PCI);Cerebrovascular Accident (CVA);Transient Ischaemic Attack(TIA);Pulmonary Embolus (PE);Deep Vein Thrombosis(DVT).

Study & Design

• Study Type: Interventional
• Study Design: Not specified